India’s Biovet To Be World’s Second Biosafety Level 4 Facility; To First Work On FMD Vaccines
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India will soon be host to the world's second Biosafety Level 4 facility for developing, manufacturing and testing animal health care products like vaccines